Severe Acute Respiratory-Syndrome Treatment Global Market Report 2024

Severe Acute Respiratory-Syndrome Treatment Global Market Report 2024

Including: 1) By Drug Class: Antibiotics; Antiviral; Corticosteroids; Monoclonal Antibodies2) By Route Of Administration: Oral; Intravenous3) By Indication: Severe Acute Respiratory Syndrome COVID-19 (SARS-CoV); Severe Acute Respiratory Syndrome COVID-19 2 (SARS‑CoV‑2)4) By Distribution Channel: Hospital Pharmacies; Retail PharmaciesCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Merck And Co Inc.; Novartis AG


Severe Acute Respiratory-Syndrome Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on severe acute respiratory-syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for severe acute respiratory-syndrome treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The severe acute respiratory-syndrome treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Drug Class: Antibiotics; Antiviral; Corticosteroids; Monoclonal Antibodies; Other Drug Classes

2) By Route Of Administration: Oral; Intravenous

3) By Indication: Severe Acute Respiratory Syndrome COVID-19 (SARS-CoV); Severe Acute Respiratory Syndrome COVID-19 2 (SARS‑CoV‑2)

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Merck And Co Inc.; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Severe Acute Respiratory-Syndrome Treatment Market Characteristics
3. Severe Acute Respiratory-Syndrome Treatment Market Trends And Strategies
4. Severe Acute Respiratory-Syndrome Treatment Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Severe Acute Respiratory-Syndrome Treatment Market Size and Growth
5.1. Global Severe Acute Respiratory-Syndrome Treatment Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Severe Acute Respiratory-Syndrome Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Severe Acute Respiratory-Syndrome Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Severe Acute Respiratory-Syndrome Treatment Market Segmentation
6.1. Global Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antibiotics
Antiviral
Corticosteroids
Monoclonal Antibodies
Other Drug Classes
6.2. Global Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Route Of Administration , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Intravenous
6.3. Global Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‑CoV‑2)
6.4. Global Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
7. Severe Acute Respiratory-Syndrome Treatment Market Regional And Country Analysis
7.1. Global Severe Acute Respiratory-Syndrome Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Severe Acute Respiratory-Syndrome Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Severe Acute Respiratory-Syndrome Treatment Market
8.1. Asia-Pacific Severe Acute Respiratory-Syndrome Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Severe Acute Respiratory-Syndrome Treatment Market
9.1. China Severe Acute Respiratory-Syndrome Treatment Market Overview
9.2. China Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Severe Acute Respiratory-Syndrome Treatment Market
10.1. India Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Severe Acute Respiratory-Syndrome Treatment Market
11.1. Japan Severe Acute Respiratory-Syndrome Treatment Market Overview
11.2. Japan Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Severe Acute Respiratory-Syndrome Treatment Market
12.1. Australia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Severe Acute Respiratory-Syndrome Treatment Market
13.1. Indonesia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Severe Acute Respiratory-Syndrome Treatment Market
14.1. South Korea Severe Acute Respiratory-Syndrome Treatment Market Overview
14.2. South Korea Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Severe Acute Respiratory-Syndrome Treatment Market
15.1. Western Europe Severe Acute Respiratory-Syndrome Treatment Market Overview
15.2. Western Europe Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Severe Acute Respiratory-Syndrome Treatment Market
16.1. UK Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Severe Acute Respiratory-Syndrome Treatment Market
17.1. Germany Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Severe Acute Respiratory-Syndrome Treatment Market
18.1. France Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Severe Acute Respiratory-Syndrome Treatment Market
19.1. Italy Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Severe Acute Respiratory-Syndrome Treatment Market
20.1. Spain Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Severe Acute Respiratory-Syndrome Treatment Market
21.1. Eastern Europe Severe Acute Respiratory-Syndrome Treatment Market Overview
21.2. Eastern Europe Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Severe Acute Respiratory-Syndrome Treatment Market
22.1. Russia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Severe Acute Respiratory-Syndrome Treatment Market
23.1. North America Severe Acute Respiratory-Syndrome Treatment Market Overview
23.2. North America Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Severe Acute Respiratory-Syndrome Treatment Market
24.1. USA Severe Acute Respiratory-Syndrome Treatment Market Overview
24.2. USA Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Severe Acute Respiratory-Syndrome Treatment Market
25.1. Canada Severe Acute Respiratory-Syndrome Treatment Market Overview
25.2. Canada Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Severe Acute Respiratory-Syndrome Treatment Market
26.1. South America Severe Acute Respiratory-Syndrome Treatment Market Overview
26.2. South America Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Severe Acute Respiratory-Syndrome Treatment Market
27.1. Brazil Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Severe Acute Respiratory-Syndrome Treatment Market
28.1. Middle East Severe Acute Respiratory-Syndrome Treatment Market Overview
28.2. Middle East Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Severe Acute Respiratory-Syndrome Treatment Market
29.1. Africa Severe Acute Respiratory-Syndrome Treatment Market Overview
29.2. Africa Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Severe Acute Respiratory-Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Severe Acute Respiratory-Syndrome Treatment Market Competitive Landscape And Company Profiles
30.1. Severe Acute Respiratory-Syndrome Treatment Market Competitive Landscape
30.2. Severe Acute Respiratory-Syndrome Treatment Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. F. Hoffmann-La Roche Ltd.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. AbbVie Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Merck And Co Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Novartis AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Severe Acute Respiratory-Syndrome Treatment Market Other Major And Innovative Companies
31.1. Bristol Myers Squib company
31.2. GlaxoSmithKline plc
31.3. AstraZeneca plc
31.4. Sanofi SA
31.5. Eli Lilly And Company
31.6. Gilead Sciences Inc.
31.7. Amgen Inc.
31.8. Johnson And Johnson Private Limited
31.9. Moderna Inc.
31.10. Regeneron Pharmaceuticals Inc.
31.11. Hetero labs Ltd.
31.12. Alexion Pharmaceuticals Inc.
31.13. Cadila healthcare Ltd.
31.14. Genentech Inc.
31.15. Cipla Ltd.
32. Global Severe Acute Respiratory-Syndrome Treatment Market Competitive Benchmarking
33. Global Severe Acute Respiratory-Syndrome Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Severe Acute Respiratory-Syndrome Treatment Market
35. Severe Acute Respiratory-Syndrome Treatment Market Future Outlook and Potential Analysis
35.1 Severe Acute Respiratory-Syndrome Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Severe Acute Respiratory-Syndrome Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Severe Acute Respiratory-Syndrome Treatment Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings